NO20001172L - Fremgangsmõte ved økning av benvolum - Google Patents
Fremgangsmõte ved økning av benvolumInfo
- Publication number
- NO20001172L NO20001172L NO20001172A NO20001172A NO20001172L NO 20001172 L NO20001172 L NO 20001172L NO 20001172 A NO20001172 A NO 20001172A NO 20001172 A NO20001172 A NO 20001172A NO 20001172 L NO20001172 L NO 20001172L
- Authority
- NO
- Norway
- Prior art keywords
- procedure
- bone volume
- increasing bone
- increasing
- volume
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5821897P | 1997-09-09 | 1997-09-09 | |
| PCT/US1998/018337 WO1999012550A1 (fr) | 1997-09-09 | 1998-09-04 | Procede d'augmentation du volume osseux |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20001172D0 NO20001172D0 (no) | 2000-03-07 |
| NO20001172L true NO20001172L (no) | 2000-05-08 |
Family
ID=22015432
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20001172A NO20001172L (no) | 1997-09-09 | 2000-03-07 | Fremgangsmõte ved økning av benvolum |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1035853A1 (fr) |
| JP (1) | JP2001515863A (fr) |
| CN (1) | CN1269720A (fr) |
| AR (1) | AR013478A1 (fr) |
| AU (1) | AU9130298A (fr) |
| BR (1) | BR9811775A (fr) |
| CA (1) | CA2303799A1 (fr) |
| CO (1) | CO5070621A1 (fr) |
| HU (1) | HUP0003584A3 (fr) |
| ID (1) | ID24759A (fr) |
| IL (1) | IL134759A0 (fr) |
| NO (1) | NO20001172L (fr) |
| PE (1) | PE118899A1 (fr) |
| PL (1) | PL339297A1 (fr) |
| SK (1) | SK3402000A3 (fr) |
| WO (1) | WO1999012550A1 (fr) |
| ZA (1) | ZA988229B (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE281432T1 (de) | 1999-03-05 | 2004-11-15 | Univ Duke | C-16 ungesätigte fp-selektive prostaglandin analoge |
| US6894175B1 (en) | 1999-08-04 | 2005-05-17 | The Procter & Gamble Company | 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use |
| US20020172693A1 (en) | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
| US20020037914A1 (en) | 2000-03-31 | 2002-03-28 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
| US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3607293A (en) * | 1992-02-05 | 1993-09-03 | Merck & Co., Inc. | Implant therapy for bone growth stimulation |
| HN1996000101A (es) * | 1996-02-28 | 1997-06-26 | Inc Pfizer | Terapia combinada para la osteoporosis |
-
1998
- 1998-09-04 CN CN98808884A patent/CN1269720A/zh active Pending
- 1998-09-04 BR BR9811775-0A patent/BR9811775A/pt not_active Application Discontinuation
- 1998-09-04 PL PL98339297A patent/PL339297A1/xx unknown
- 1998-09-04 EP EP98943532A patent/EP1035853A1/fr not_active Withdrawn
- 1998-09-04 SK SK340-2000A patent/SK3402000A3/sk unknown
- 1998-09-04 IL IL13475998A patent/IL134759A0/xx unknown
- 1998-09-04 HU HU0003584A patent/HUP0003584A3/hu unknown
- 1998-09-04 WO PCT/US1998/018337 patent/WO1999012550A1/fr not_active Ceased
- 1998-09-04 JP JP2000510447A patent/JP2001515863A/ja not_active Withdrawn
- 1998-09-04 AU AU91302/98A patent/AU9130298A/en not_active Abandoned
- 1998-09-04 CA CA002303799A patent/CA2303799A1/fr not_active Abandoned
- 1998-09-04 ID IDW20000638A patent/ID24759A/id unknown
- 1998-09-08 AR ARP980104480A patent/AR013478A1/es not_active Application Discontinuation
- 1998-09-09 ZA ZA988229A patent/ZA988229B/xx unknown
- 1998-09-09 CO CO98051809A patent/CO5070621A1/es unknown
- 1998-09-09 PE PE1998000855A patent/PE118899A1/es not_active Application Discontinuation
-
2000
- 2000-03-07 NO NO20001172A patent/NO20001172L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AR013478A1 (es) | 2000-12-27 |
| WO1999012550A1 (fr) | 1999-03-18 |
| ID24759A (id) | 2000-08-03 |
| ZA988229B (en) | 1999-03-09 |
| PL339297A1 (en) | 2000-12-04 |
| CN1269720A (zh) | 2000-10-11 |
| NO20001172D0 (no) | 2000-03-07 |
| CA2303799A1 (fr) | 1999-03-18 |
| EP1035853A1 (fr) | 2000-09-20 |
| BR9811775A (pt) | 2000-08-29 |
| HUP0003584A3 (en) | 2002-12-28 |
| IL134759A0 (en) | 2001-04-30 |
| HUP0003584A2 (hu) | 2001-02-28 |
| AU9130298A (en) | 1999-03-29 |
| PE118899A1 (es) | 2000-02-03 |
| JP2001515863A (ja) | 2001-09-25 |
| CO5070621A1 (es) | 2001-08-28 |
| SK3402000A3 (en) | 2000-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Servière et al. | Isofrequency labelling revealed by a combined [14C]‐2‐deoxyglucose, electrophysiological, and horseradish peroxidase study of the inferior colliculus of the cat | |
| ATE239474T1 (de) | Verwendung von levobupivacain | |
| NO20001171L (no) | FremgangsmÕte ved økning av benvolum under anvendelse av ikke naturlig forekommende FP-selektive agonister | |
| DE122011100032I1 (de) | Verwendung von n-substituierten pyridonen als tumornekrose-faktor alpha hemmer. | |
| YU49315B (sh) | Inhibitor protein kinaze c, njegove farmaceutske formulacije i postupak za dobijanje | |
| DE69010336D1 (de) | Pharmazeutische zusammensetzung zum abnehmen. | |
| PT888353E (pt) | Novas n-7-heterociclil-pirrolo¬2,3-d|pirimidinas e sua aplicacao | |
| ATE252368T1 (de) | Kosmetische oder pharmazeutische zubereitungen mit vermindertem klebrigkeitsgefühl | |
| EP0751992A4 (fr) | Facteur 2 de croissance endotheliale vasculaire | |
| NO924619L (no) | (+)-alfa-(2,3-dimetoksyfenyl)-1-(2-(4-fluorfenyl)ethyl)-4-piperidinmetanol | |
| DE69414398D1 (de) | Heterocyclische neurokinin-antagonisten | |
| CY1111912T1 (el) | Μεθοδος αναστολης της δραστηριοτητας των οστεοκλαστων | |
| EP1806135A3 (fr) | Utilisation d'un inhibiteur de la protéine tyrosine tel qu'une génistéine pour le traitement d'une rétinopathie diabétique ou une inflammation oculaire | |
| DE69835680D1 (de) | Therapeutische verwendung von smr1 protein und seinen aktiven derivaten | |
| ATE240730T1 (de) | Verwendung von levobupivacaine in gesichtschirugie | |
| NO20001172L (no) | Fremgangsmõte ved økning av benvolum | |
| DK0840607T3 (da) | Ny medicinsk anvendelse | |
| FR2739553B1 (fr) | Utilisation d'antagonistes de la bradykinine pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute | |
| Fusi et al. | Ca2+ entry blocking and contractility promoting actions of norbormide in single rat caudal artery myocytes | |
| DK1331940T3 (da) | Anvendelse af det lange pentraxin PTX3 til behandling af sygdomme forårsaget af ændret aktivering af vækstfaktoren FGF-2 | |
| YU39396A (sh) | Upotreba izolovanog prirodnog proteina gojaznosti za pripremu leka i njegova farmaceutska formulacija | |
| IT8921128A0 (it) | Metodo per la determinazione della attivita' funzionale della proteina s nel plasma umano. | |
| McCrohan et al. | Characterization of an identified cerebrobuccal neuron containing the neuropeptide APGWamide (Ala-Pro-Gly-Trp-NH2) in the snail Lymnaea stagnalis | |
| Akamatsu et al. | Vasopressin phosphorylates HSP27 in aortic smooth muscle cells | |
| Kovács et al. | Influence of Z-prolyl-D-leucine on α-MPT-induced catecholamine utilization in specific mouse brain nuclei |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |